Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
1 Result for "
CTX009
" in MedChemExpress (MCE) Product Catalog:
Products (1)
1 Results for "CTX009" in MCE Product Catalog:
Cat. No.: HY-P991033
CAS No.: 2923284-73-3
Synonyms: CTX-009; ES 104
Tovecimig (CTX-009) is a bispecific antibody targeting DLL4 and VEGF-A. Tovecimig contains two single-chain variable fragments (scFv) that bind human DLL4, and these fragments are linked to the C-terminus of the heavy chain that binds human VEGF-A. Tovecimig blocks the DLL4/NOTCH1 and VEGF signaling pathways, inhibiting DLL4-mediated Notch signaling and VEGF-A-mediated angiogenic signaling in tumor angiogenesis. Tovecimig can be used in research on refractory metastatic colorectal cancer, advanced biliary tract cancer, solid tumors, gastric cancer, and colon cancer .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
